Clinical trials: CGM

Hypoglycemia, Newborn Morbidity

Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia

• Terminated
• Age: Up to 60 days
• Medical device
• Results posted

Our aim is to determine the feasibility of using continuous glucose monitors (CGMs) in infants with low blood glucose to improve how we care for these infants.

Trial name

NCT02300285

Testing

Continuous Glucose Monitoring

Where

United States

Volunteers

6 people

Sponsor

Boston Children's Hospital